Literature DB >> 11013608

[Magnetic resonance imaging of hemorrhagic transformation in ischemic posterior infarction].

M Reimann1, L Niehaus, R Lehmann.   

Abstract

PURPOSE: To describe the incidence, time course, and clinical correlates of hemorrhagic transformation (HT) of ischemic stroke in the posterior cerebral artery territory.
METHODS: Within 42 months 48 patients with 52 occipital lobe infarctions were examined by T1- and T2-weighted MR imaging. The extent and distribution of secondary hemorrhage were analysed at different intervals after stroke. Volume of ischemic and hemorrhagic infarction was measured planimetrically.
RESULTS: HT was observed in 71% of the infarcts between the 5th day and up to 1 year after stroke. HT was most frequently (88%) observed in the 2nd and 3rd month. HT was present in 55% of small infarcts (< 10 cm3), in 88% of medium size (10-50 cm3), and in all large (> 50 cm3) infarcts. In 92% HT presented with petechial bleedings within the cortex (64%) or less frequently (28%) in subcortical structures. The latter types of HT showed no progression and did not increase the clinical deficits. Space-occupying bleedings occurred in only two large defects.
CONCLUSIONS: In ischemic posterior infarction, HT can frequently be detected within the first three months after stroke and is predominantly of the petechial type and seems not to be relevant with regard to clinical deficits.

Entities:  

Mesh:

Year:  2000        PMID: 11013608     DOI: 10.1055/s-2000-7170

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  2 in total

1.  Use of 3-D magnetic resonance electrical impedance tomography in detecting human cerebral stroke: a simulation study.

Authors:  Nuo Gao; Shan-An Zhu; Bin He
Journal:  J Zhejiang Univ Sci B       Date:  2005-05       Impact factor: 3.066

2.  Genetic Algorithm for TMS Coil Position Optimization in Stroke Treatment.

Authors:  Shujie Lu; Haoyu Jiang; Chengwei Li; Baoyu Hong; Pu Zhang; Wenli Liu
Journal:  Front Public Health       Date:  2022-03-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.